Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.
Phaeochromocytomas and paragangliomas (PPGLs) are highly heterogeneous tumours with variable catecholamine biochemical phenotypes and diverse hereditary backgrounds. This analysis of 18 catecholamine-related plasma and urinary biomarkers in 365 patients with PPGLs and 846 subjects without PPGLs examined how catecholamine metabolomic profiles are impacted by hereditary background and relate to variable hormone secretion. Catecholamine secretion was assessed in a subgroup of 156 patients from whom tumour tissue was available for measurements of catecholamine contents. Among all analytes, the free catecholamine O-methylated metabolites measured in plasma showed the largest tumour-related increases relative to the reference group. Patients with tumours due to multiple endocrine neoplasia type 2 and neurofibromatosis type 1 (NF1) showed similar catecholamine metabolite and secretory profiles to patients with adrenaline-producing tumours and no evident hereditary background. Tumours from these three patient groups contained higher contents of catecholamines, but secreted the hormones at lower rates than tumours that did not contain appreciable adrenaline, the latter including PPGLs due to von Hippel-Lindau (VHL) and succinate dehydrogenase (SDH) gene mutations. Large increases of plasma dopamine and its metabolites additionally characterised patients with PPGLs due to the latter mutations, whereas patients with NF1 were characterised by large increases in plasma dihydroxyphenylglycol and dihydroxyphenylacetic acid, the deaminated metabolites of noradrenaline and dopamine. This analysis establishes the utility of comprehensive catecholamine metabolite profiling for characterising the distinct and highly diverse catecholamine metabolomic and secretory phenotypes among different groups of patients with PPGLs. The data further suggest developmental origins of PPGLs from different populations of chromaffin cell progenitors.
Institute of Clinical Chemistry and Laboratory Medicine, University of Dresden, 01307 Dresden, Germany. graeme.eisenhofer@uniklinikum-dresden.de
Graeme
G
Eisenhofer
Karel
K
Pacak
Thanh-Truc
TT
Huynh
Nan
N
Qin
Gennady
G
Bratslavsky
W Marston
WM
Linehan
Massimo
M
Mannelli
Peter
P
Friberg
Stefan K
SK
Grebe
Henri J
HJ
Timmers
Stefan R
SR
Bornstein
Jacques W M
JW
Lenders
D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000097:blood / Q000378:metabolism* / Q000652:urine; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002395:Catecholamines / Q000378:metabolism*; D002648:Child; D016000:Cluster Analysis; D005260:Female; D006801:Humans; D008297:Male; D055442:Metabolome; D008875:Middle Aged; D008954:Models, Biological; D010641:Phenotype; D010673:Pheochromocytoma / Q000097:blood / Q000378:metabolism* / Q000652:urine; D055815:Young Adult
D002395:Catecholamines